Yendamuri S, et al. - Researchers sought to assess the impact of sampling lymph nodes on the outcomes among all patients in the Surveillance, Epidemiology and End Results (SEER) from 2004 -2013 with small (<2cm) stage I NSCLC (non-small cell lung cancer) undergoing sublobar resection (wedge/segmentectomy) and no other cancer history. They noted that in the United States, many patients having sublobar resection for early-stage NSCLC do not have a single lymph node removed for pathologic examination. Presumably due to avoidance of mis-staging, the number of lymph nodes examined is observed to be associated with improved survival. This association appeared greater than the association with extent of resection (segmentectomy vs. wedge resection).